Medical Innovation Exchange

Rubius makes hard pivot after reviewing clinical data, dumping lead assets and laying off 75% of staffers

https://www.fiercebiotech.com/biotech/rubius-makes-hard-pivot-after-reviewing-clinical-data-dumping-lead-assets-and-laying-75

Leave a Comment

Your email address will not be published.

Leave the field below empty!